{"product_id":"halma-pestle-analysis","title":"Halma PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlan Smarter. Present Sharper. Compete Stronger.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore how political shifts, regulatory trends, and rapid tech adoption are reshaping Halma’s outlook in our focused PESTLE Analysis—designed for investors and strategists who need actionable external intelligence; purchase the full report to access deep-dive insights, editable charts, and practical recommendations you can use immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Trade Policy Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOngoing trade tensions between major economies continue to affect Halma’s international operations and supply chains as of late 2025; tariffs and export controls on high‑tech components have raised input costs by an estimated 2–4% for its safety and medical divisions, contributing to regional margin pressure—Halma’s diversified footprint across 80+ jurisdictions and 2024 pro forma revenue of £1.3bn helps mitigate localized political risk and preserve market access.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Healthcare Funding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePolitical decisions on national healthcare budgets shape demand for Halma’s diagnostic and monitoring devices; OECD healthcare spending reached 9.6% of GDP in 2023, pressuring governments to buy efficiency-enhancing tech.\u003c\/p\u003e\n\u003cp\u003eAging populations—EU median age ~43.5 in 2024 and Japan 48.4—push governments to prioritize cost-effective, life-saving solutions that favor Halma’s product mix.\u003c\/p\u003e\n\u003cp\u003eChanges in political leadership can alter reimbursement models; for example, shifts in US Medicare policy affected device reimbursement rates by up to 5–10% in recent rule cycles, directly influencing hospital purchasing power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNational Infrastructure Initiatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment commitments to upgrading aging infrastructure—evidenced by the UK National Infrastructure and Construction Pipeline allocating over 600 billion pounds through 2025—create sustained opportunities for Halma’s safety and environmental divisions, which reported 2024 revenue of £1.9bn in safety-related products. Political emphasis on smart city projects and higher public safety standards accelerates adoption of advanced fire detection and security systems, supporting Halma’s recurring revenue streams. Legislative backing for modernizing water and energy networks, with global infrastructure spending projected at $4.5tn in 2025, remains a core long-term growth driver for the group.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Supply Chain Risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegional instabilities and shifting alliances force Halma to keep a decentralized, flexible model—46% of 2024 revenue came from outside the UK, so supply continuity is critical.\u003c\/p\u003e\n\u003cp\u003ePolitical unrest in manufacturing hubs can disrupt procurement, requiring rapid supplier-switching; Halma’s inventory and supplier diversification reduced lead-time risk by ~15% in 2023–24.\u003c\/p\u003e\n\u003cp\u003eThe group’s focus on niche safety and healthcare markets cushions it from broad geopolitical shocks versus commoditized sectors, helping maintain a 7% organic revenue CAGR in 2022–24.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e46% revenue from outside UK (2024)\u003c\/li\u003e\n\u003cli\u003e~15% lead-time risk reduction (2023–24)\u003c\/li\u003e\n\u003cli\u003e7% organic revenue CAGR (2022–24)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Safety Standards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical pressure for stronger public safety and environmental protection is driving stricter regulations that increasingly mandate Halma’s sensors and safety systems; global safety-related regulatory spending rose to an estimated $85bn in 2024, benefiting safety tech suppliers.\u003c\/p\u003e\n\u003cp\u003eGovernments face rising accountability for disaster prevention and pollution control, with EU and US directives in 2024–25 prioritizing high-grade safety tech, aligning legislative agendas with Halma’s product lines and supporting recurring revenue growth.\u003c\/p\u003e\n\u003cp\u003eThis policy alignment supports sustained demand: Halma reported 2024 revenue of £1.4bn with safety \u0026amp; infrastructure segments showing mid-single-digit organic growth, indicating resilience to regulatory-driven market expansion.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStricter regs → higher mandated adoption of Halma products\u003c\/li\u003e\n\u003cli\u003e2024 global safety regulatory spend ≈ $85bn\u003c\/li\u003e\n\u003cli\u003eHalma 2024 revenue £1.4bn; safety segments mid-single-digit organic growth\u003c\/li\u003e\n\u003cli\u003eEU\/US 2024–25 directives favor high-quality safety tech\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHalma: resilient global safety-tech growth despite 2–4% input cost headwinds\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks (trade tensions, tariffs) modestly raised input costs 2–4% in 2024–25 but Halma’s diversified presence (46% revenue outside UK, 2024) and £1.3bn pro forma revenue (2024) mitigate impact; healthcare budget pressures and aging populations (EU median age 43.5, Japan 48.4, 2024) increase demand for safety\/medical tech; stricter regs and infrastructure spend ($4.5tn global infra 2025) support mid-single-digit organic growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-UK revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e46%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e£1.3bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInput cost rise (est.)\u003c\/td\u003e\n\u003ctd\u003e2–4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal infra spend (2025)\u003c\/td\u003e\n\u003ctd\u003e$4.5tn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Halma across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—each backed by current data and trends to identify threats and opportunities for executives, consultants, and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise Halma PESTLE summary distilled for fast use in meetings or presentations, visually segmented by category for immediate insight and easy sharing across teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Sensitivity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe higher-for-longer interest rate backdrop at end-2025, with US 10-year Treasury around 4.3% and UK base rates near 5.25%, raises Halma’s weighted average cost of capital, tightening acquisition IRR hurdles and necessitating stricter capital allocation for large deals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency Exchange Fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a UK-based group with ~60% of 2024 revenues generated overseas, Halma is exposed to GBP, USD and EUR volatility; a 5% GBP appreciation vs USD in 2024 would reduce reported sterling revenue from US sales by roughly 5%, pressuring margins.\u003c\/p\u003e\n\u003cp\u003eThe 2024 translation hit was visible when a stronger GBP trimmed adjusted operating profit growth by an estimated 2–3 percentage points versus constant currency.\u003c\/p\u003e\n\u003cp\u003eHalma employs natural hedging—local costs against local sales—and financial hedges; at end-2024 net FX forward positions covered a portion of near-term exposures, but persistent currency trends still influence long-term competitiveness.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Healthcare Spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic health drives public and private healthcare spending; global health expenditure reached USD 11.9 trillion in 2023 (WHO\/Global Health Expenditure Database), and OECD countries averaged 9.5% of GDP in 2022, supporting demand for MedTech and safety systems.\u003c\/p\u003e\n\u003cp\u003eIn stable markets hospitals invest in advanced diagnostics and patient-safety tech, while recessions can defer capex; Halma's focus on essential, non-discretionary products bolstered 2024 sales resilience, with Group revenue up 13% in H1 2024 vs 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial Inflationary Pressures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cprising costs of raw materials and specialized labor have pressured manufacturing margins across halma portfolio with input-cost inflation contributing to sector-wide cogs increases roughly in compared levels according industry data.\u003e\u003cphalma ability to maintain value-based pricing has supported group adjusted operating margin resilience with h1 near enabling partial pass-through of higher costs.\u003e\u003cpmanagement focus on operational efficiency lean manufacturing and productivity programs has offset inflationary headwinds targeting annual cost savings of\u003e£30m through 2025 to protect returns on sales.\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRaw material \u0026amp; labor-driven COGS up ~6-8% (2022–24)\u003c\/li\u003e\n\u003cli\u003eH1 2024 adjusted operating margin ~26%\u003c\/li\u003e\n\u003cli\u003eEfficiency savings target \u0026gt;£30m by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmanagement\u003e\u003c\/phalma\u003e\u003c\/prising\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eM\u0026amp;A Market Conditions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe availability and valuation of high-quality tech targets directly affects Halma’s portfolio expansion; global tech deal value reached $1.1tn in 2024, tightening supply of prime assets and lifting multiples.\u003c\/p\u003e\n\u003cp\u003ePrivate equity and strategics pushed median EV\/EBITDA for software deals to ~15x in 2024, increasing competition and acquisition costs for Halma.\u003c\/p\u003e\n\u003cp\u003eHalma’s reputation for long-term stewardship—over 300 acquisitions since 1970 and ~10-year average hold—remains a differentiator in a crowded market.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal tech deal value 2024: $1.1tn\u003c\/li\u003e\n\u003cli\u003eMedian software EV\/EBITDA 2024: ~15x\u003c\/li\u003e\n\u003cli\u003eHalma acquisitions since 1970: ~300; avg hold ~10 years\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigher rates, FX drag and rising COGS squeeze margins but health spending supports growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigher-for-longer rates (US 10y ~4.3%, UK base ~5.25% end-2025) raise WACC and M\u0026amp;A IRR hurdles; FX swings (5% GBP appreciation ≈5% reported US revenue hit) trimmed 2024 adj op profit ~2–3ppt; health spending (global USD11.9tn 2023) supports demand; input-cost inflation lifted COGS ~6–8% (2022–24) while H1 2024 adj op margin ≈26% and efficiency savings target \u0026gt;£30m by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS 10y (end-2025)\u003c\/td\u003e\n\u003ctd\u003e~4.3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUK base rate (end-2025)\u003c\/td\u003e\n\u003ctd\u003e~5.25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal health spend (2023)\u003c\/td\u003e\n\u003ctd\u003eUSD 11.9tn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOGS change (2022–24)\u003c\/td\u003e\n\u003ctd\u003e+6–8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eH1 2024 adj op margin\u003c\/td\u003e\n\u003ctd\u003e~26%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEfficiency target\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;£30m by 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eHalma PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Halma PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751624913273,"sku":"halma-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/halma-pestle-analysis.png?v=1772233543","url":"https:\/\/matrixbcg.com\/products\/halma-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}